ARKG vs SGOV
ARK Genomic Revolution ETF vs iShares 0-3 Month Treasury Bond ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
SGOV—
iShares 0-3 Month Treasury Bond ETF
0-3 month T-bills, low-duration cash alternative.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | SGOV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
Holdings data unavailable for ARKG.
SGOV top holdings
Holdings data unavailable for SGOV.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About SGOV
SGOV (iShares 0-3 Month Treasury Bond ETF) is 0-3 month T-bills, low-duration cash alternative.